Aquatic Capital Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-197
Closed -$5K 1638
2022
Q2
$5K Buy
197
+194
+6,467% +$6.6K ﹤0.01% 1052
2022
Q1
$0 Buy
+3
New +$148 ﹤0.01% 1605

Other funds holding VBIV

Aquatic Capital Management's VBIV Position: Q3 2022 in Review

Aquatic Capital Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2022, closing a stake of 197 shares — an estimated $5K sold.

Aquatic Capital Management first reported a position in VBIV in Q1 2022 and held it in 2 quarters. The position peaked at $5K in Q2 2022. 127 funds tracked by Wall St. Rank hold VBIV as of Q3 2022.

  • Aquatic Capital Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 197 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2022, an estimated $5K.
  • Aquatic Capital Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2022 and held it in 2 quarters.
  • Aquatic Capital Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $5K in Q2 2022.
  • 127 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2022.

Based on Aquatic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.